FDA Inspection
Octapharma ABFDA Inspection 1218250 - Octapharma AB - September 19, 2023
Discuss this record with AI
Record Details
This FDA Inspection record concerns Octapharma AB, with an inspection on September 19, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
Open in Dashboard
ID · 3645f477-d675-40fc-90b8-3704a595408d
Violation Codes3
21 CFR 211.100(b)21 CFR 211.110(a)21 CFR 211.67(a)
Full citation text and observation details available on the Dashboard.